Technique to process xenogenic tissues for cardiovascular implantation – A preliminary report

CURRENT SCIENCE, VOL. 91, NO. 8, 25 OCTOBER 2006 1068 *For correspondence. (e-mail: [email protected]) 3. Naoe, T. et al., Analysis of genetic polymorphism in NQO1, GSTM1, GST-T1 and CYP3A4 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin. Cancer Res., 2000, 6, 4091–4095. 4. Kawase, H., Hamajima, N., Tamakohi, A., Wakai, K., Saito, T. and Tajima, K., Triplex polymerase chain reaction with confronting two-pair primers (PCR–CTPP) for NQO1 C609T, GSTM1 and GSTT1 polymorphisms: a convenient genotyping method. Asia Pac. J. Cancer Pre., 2003, 4, 67–70. 5. Zhang, J. H. et al., NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J. Gastroenterol., 2003, 9, 1390–1393. 6. Nebert, D. W., Roe, A. M., Vandale, S. E., Bingham, E. and Oakley, G. G., NAD(P)H: quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease. Genet. Med., 2002, 4, 62–70. 7. Moran, J. L., Siegel, D. and Ross, D., A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H: quinine oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl. Acad. Sci. USA, 1999, 96, 8150–8155. 8. Larson, R. A. et al., Prevalence of the inactivating C→T polymorphism in the NAD(P)H: quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood, 1999, 94, 803–807. 9. Ozawa, S. et al., Analysis of bronchial bulky DNA adduct levels and CYP2C9, GST-P1 and NQO1 genotypes in a Hungarian study population with pulmonary disease. Carcinogenesis, 1999, 20, 991–995. 10. Kelsey, K. T. et al., Ethnic variation in the prevalence of a common NAD(P)H quinine oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br. J. Cancer, 1997, 76, 852–854. 11. Wikipedia, the free encyclopedia, http://en.wikipedia.org/ 12. Biramijamal, F., Sanati, M. H., Iravanloo, G., Shamimi, K. and Farhood, D., Assessing NAD(P)H: quinone oxidoreductase C→T polymorphism by simple PCR method. Iranian J. Biotechnol., 2004, 2, 203–206. 13. Hamajima, N. et al., NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int. J. Clin. Oncol., 2002, 7, 103–108.